MSDS 269 MultiHance
MSDS 269 MultiHance
MSDS 269 MultiHance
16
Page 1/10
Version 1
Reviewed on 11/07/2011
1.2 Relevant identified uses of the substance or mixture and uses advised against
We recommend that you use this product in a manner consistent with the listed use. If your intended use is not
consistent with the stated use, please contact your sales or technical service representative.
Application of the substance / the preparation
Indicated for intravenous use as an adjunct to MRI in Central Nervous System imaging.
Chemical Family: Paramagnetic agent.
Molecular Formula: C22H28GdN3O11 2(C7H17NO5) (gadobenate dimeglumine)
CAS Number: 127000-20-8 (gadobenate dimeglumine).
2: Hazards identification
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
The product is not classified according to the CLP regulation.
Classification according to Directive 67/548/EEC or Directive 1999/45/EC Not applicable.
Information concerning particular hazards for human and environment:
The product does not have to be labelled due to the calculation procedure of international guidelines.
(Contd. on page 2)
USA
33.0.16
Page 2/10
Version 1
Reviewed on 11/07/2011
Classification system:
The classification was made according to the latest editions of international substances lists, and expanded
upon from company and literature data.
Health = 0
Fire = 0
Reactivity = 0
HMIS-ratings (scale 0 - 4)
HEALTH
FIRE
REACTIVITY 0
Health = 0
Fire = 0
Reactivity = 0
3: Composition/information on ingredients
3.1 Substances
Active Ingredients:
CAS: 127000-20-8 Gadobenic Acid, Dimeglumine Salt
RTECS: LZ4306000
3.2 Mixtures
Description: Mixture: consisting of the following components.
(Contd. on page 3)
USA
33.0.16
Page 3/10
Version 1
Reviewed on 11/07/2011
Dangerous Components
CAS N
Description
Void
Not Dangerous Components
CAS N
Description
CAS: 127000-20-8 Gadobenic Acid, Dimeglumine Salt
RTECS: LZ4306000
CAS: 7732-18-5
Water USP
EINECS: 231-791-2
RTECS: ZC0110000
%
52.9%
NA%
Additional information: For the wording of the listed risk phrases refer to section 16.
*
4.2 Most important symptoms and effects, both acute and delayed See also Section 2 and 11.
4.3 Indication of any immediate medical attention and special treatment needed:
No further relevant information available.
Means of Specific and Immediate Treatment to Keep at the Workplace: No special measures required.
Note to physicians: None.
*
5: Firefighting measures
5.1 Extinguishing media
Suitable extinguishing agents: In case of fire, flood with Water
For safety reasons unsuitable extinguishing agents: Unknown.
5.2 Special hazards arising from the substance or mixture See also Section 10.
Hazardous Combustion Products:
Carbon Dioxide (CO)
In the absence of Oxygen: Carbon Monoxide (COx)
(Contd. on page 4)
USA
33.0.16
Page 4/10
Version 1
Reviewed on 11/07/2011
33.0.16
Page 5/10
Version 1
Reviewed on 11/07/2011
Material of Gloves:
Latex, Latex / Nitrile or Nitrile Gloves.
The selection of the suitable gloves does not only depend on the material, but also on further marks of quality
and varies from manufacturer to manufacturer.
Selection of the glove material on consideration of the penetration times, rates of diffusion and the
degradation.
The glove material has to be impermeable and resistant to the product/ the substance/ the mixture.
Penetration Time of Glove Material:
The exact break through time has to be found out by the manufacturer of the protective gloves and has to be
observed.
Eye Protection:
Wear safety glasses (ANSI Z87.1)
(Contd. on page 6)
33.0.16
Page 6/10
Version 1
Reviewed on 11/07/2011
Liquid
Colorless
Undistinguishable
Not determined.
pH-value:
Melting point/Melting range:
Boiling point/Boiling range:
6.5 - 7.5
Undetermined.
100C
Flash point:
Not applicable.
Not applicable.
Ignition temperature:
Decomposition temperature:
Not determined.
Auto igniting:
Danger of explosion:
Flammability Limits:
Lower:
Upper:
Explosion limits:
Lower:
Upper:
Not determined.
Not determined.
Vapor pressure:
Not determined.
Density at 20C:
1.22 g/cm
Relative density
Not determined.
Vapour density
Evaporation rate
Fully miscible.
T = 20 C, = 9.2 mPas
T = 37 C, = 5.3 mPas
Not determined.
No further relevant information available.
33.0.16
Page 7/10
Version 1
Reviewed on 11/07/2011
33.0.16
Page 8/10
Version 1
Reviewed on 11/07/2011
Any Eventual Delayed Effect after Prolonged Exposure: No evidence reported in working practice.
*
Void
Void
(Contd. on page 9)
USA
33.0.16
Page 9/10
Version 1
Reviewed on 11/07/2011
Void
Void
No
Not applicable.
33.0.16
Page 10/10
Version 1
Reviewed on 11/07/2011